Daniel A. Nachtsheim

Author

University of California San Diego Medical Center

Also Known As

D A Nachtsheim, D Nachtsheim, D. A. NACHTSHEIM, D. Nachtsheim, D.A. Nachtsheim, DANIEL A. NACHTSHEIM, Daniel A. Nachtsheim, Daniel Nachtsheim, R Barnes, R D Williams

Publications

913

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Medical Center University of California San Diego Mercy Hospital and Medical Center Scripps Health Letterman Army Medical Center

About

Daniel A. Nachtsheim is an author at University of California San Diego Medical Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	458
2	Engineering	1	1	115
3	Public Health	1	1	74
4	Allergy	1	1	45
5	Cell Biology	1	1	14

Daniel A. Nachtsheim

Publications

878

Citations

H-Index

Page 1

	Year	Citations
High-Resolution Ultrasonography of Scrotal Pathology George R. Leopold, Victor L. Woo, F. William Scheible, Radiology Medical UltrasoundEngineeringHigh-resolution UltrasonographyDiagnosisTesticular Tumours	1979	115
Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture Jack Geller, Lida Sionit, Christine Partido, The Prostate	1998	99
Comparison of Prostatic Cancer Tissue Dihydrotestosterone Levels at the Time of Relapse Following Orchiectomy or Estrogen Therapy Jack Geller, Jerry Albert, Daniel A. Nachtsheim, The Journal of Urology	1984	98
The Effect of Testicular Torsion on Contralateral Testis and the Production of Antisperm Antibodies in Rabbits Thomas S. Cerasaro, Daniel A. Nachtsheim, Fernando Díaz Otero, The Journal of Urology SpermatogenesisFertilityContralateral TestisGynecologyPathology	1984	74
Latent Residual Tumor Following External Radiotherapy for Prostate Adenocarcinoma Daniel A. Nachtsheim, Jack W. McAninch, Ray E. Stutzman, The Journal of Urology Residual TumorSurgical OncologyUrologyExternal Supervoltage RadiotherapyRadiation Therapy	1978	65
Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. Daniel A. Nachtsheim, Ann Rearden PubMed	1996	54
Tissue Dihydrotestosterone Levels and Clinical Response to Hormonal Therapy in Patients with Advanced Prostate Cancer* Jack Geller, DANIEL J. DE LA VEGA, Jerry Albert, The Journal of Clinical Endocrinology & Metabolism	1984	49
Ultrasonography of Testis Tumors Daniel A. Nachtsheim, F. William Scheible, Barbara B. Gosink The Journal of Urology	1983	46
Peyronie's Disease is Associated with an HLA Class II Antigen, HLA-DQ5, Implying an Autoimmune Etiology Daniel A. Nachtsheim, Ann Rearden The Journal of Urology HlaImmunohematologyHistocompatibilityDisease EtiologyImmunodeficiencies	1996	45
2001 American Urological Association Gallup Survey: Changes In Physician Practice Patterns, Satisfaction With Urology, And Treatment Of Prostate Cancer And Erectile Dysfunction Michael P. O’Leary, Neil Baum, Richard Blizzard, The Journal of Urology	2002	40

Page 1